LITTLE FALLS, N.J. (MedPage Today) -- The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French researchers found.

PRINCETON, N.J. (MedPage Today) -- A bone growth agent increasingly used during spinal fusion operations raises medical costs and the risk of complications related to anterior cervical fusion surgery, according to a new study.

SAN FRANCISCO (MedPage Today) -- Golimumab (Simponi) alleviates rheumatoid arthritis symptoms in patients who have previously received another tumor necrosis factor-alpha inhibitor, researchers found.

WHEELING, W.Va. (MedPage Today) -- An investigational oral drug that inhibits mast cell activity produced modest responses in rheumatoid arthritis in a phase IIa study, French researchers said.

New insight into the autoimmune triggers for rheumatoid arthritis among smokers with shared epitope genes.

Highlights of the American College of Rheumatology 70th Annual Scientific Meeting - Nov. 12-17, San Diego, USA.

The FDA approved HUMIRA® (adalimumab) for reducing signs and symptoms of active arthritis in patients with psoriatic arthritis.

Adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.